|
 |
FemaraThis page contains recent news articles, when available, and an overview of Femara but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Many women who have had breast cancer take medicines called aromatase inhibitors -- such as Pfizer's Aromasin, Novartis' Femara and AstraZeneca Plc's ... Reuters Govt to examine Sun's breast cancer drug - 05 Jan 2010 Letrozole is the original drug developed by Swiss company Novartis, which it sells under the brand name Femara to treat breast cancer in post-menopausal ... Economic Times ì„?류 í•¨ìœ ë¬¼ì§ˆ, ì•„ë¡œë§ˆíƒ€ì œ ì–µì œ 효과 있어 - 05 Jan 2010 ...많ì?€ 여성들ì?€ í™”ì?´ìž?ì?˜ 'ì•„ë¡œë§ˆì‹ (Aromasin)', 노바티스ì?˜ '페마ë?¼(Femara)'와 ê°™ì?€ ì•„ë¡œë§ˆíƒ€ì œ ì–µì œì œë¥¼ ìœ ë°©ì•” ì¹˜ë£Œì œë¡œ ë³µìš©í•˜ê³ ìžˆë‹¤. ... 데일리팜 STOCKS NEWS EUROPE-Novartis drops as analysts recommend selling - Dec 10, 2009 ...the loss of about $13 billion gross profit over the next 5-6 years following the genericisation of Gleevec, Diovan, Femara, Zometa and many others." Reuters San Diego's BioTheranostics Gears Up to Sell Test That Predicts Breast Cancer ... - Dec 12, 2009 ...which patients had a three-fold greater likelihood of benefitting from a standard aromatase inhibitor therapy from Novartis, called letrozole (Femara). ... Xconomy Bone Drugs Also Helpful In Beating Breast Cancer - Dec 11, 2009 Zzoledronic acid was found safe to be given to women with breast cancer and who were being treated with the aromatase inhibitor Femara (letrozole), ... Visit Bulgaria Healthcare on My Wife's Mind - Dec 24, 2009 The drug is Femara. We pay for it ourselves- about 300./mo. But the lesson is that the R & D was done and there are 2 more waiting in the wings that some ... RedState (blog) Letrozole Superior To Tamoxifen In Breast Cancer - Dec 24, 2009 The aromatase inhibitor letrozole (Femara) produces a significant survival benefit over tamoxifen when used as adjuvant therapy for postmenopausal women ... Medical News Today Zoledronic Acid Improves Bone Loss Associated With Adjuvant AI Therapy in ... - Dec 15, 2009 Five-year follow-up results of the Zometa-Femara Adjuvant Synergy Trial (Z-FAST) were presented here on December 12 at the 32nd Annual San Antonio Breast ... DG News SABCS: No Cancer Benefit for Preop Bone Drug - Dec 11, 2009 The same strategy using the aromatase inhibitor letrozole (Femara) reduced proliferation (indicated by its marker Ki67) by 52% with a similar benefit for ... MedPage Today Tamoxifen, Endoxifen, and CYP2D6: The Rules for Evaluating a Predictive Factor - Dec 17, 2009 ...favor of anastrozole (Arimidex) and letrozole (Femara),[1,2] which did not translate into a survival advantage, as confirmed in a recent meta-analysis. ... Cancer Network Treatment Updates - Dec 23, 2009 Premenopausal women who took tamoxifen for five years, followed by another aromatase inhibitor called Femara (letrozole), were less likely to have a ... Curetoday.com (press release) Taro Sends Important Update to Shareholders - Dec 11, 2009 Femara®, the branded form of letrozole, states in its package insert that “You should not take Femara® if you are premenopausal ¦ as it may cause harm to an ... PharmaLive.com (press release) BIG 1-98: Benefits of letrozole over tamoxifen greater than previously reported - Dec 14, 2009 ...randomized, multicenter trial comparing letrozole (Femara, Novartis) vs. tamoxifen. Results from BIG 1-98 presented in 2008 showed a nonsignificant 13% ... HemOncToday 'ìœ ë°©ì•”' 환ìž? 수명 연장 효과 '페마ë?¼ > 타목시펜' - Dec 25, 2009 29ì?¼ 하버드ì?˜ëŒ€ 연구팀ì?´ ë°?힌 BIG 1-98 ë?¼ëŠ” ìž„ìƒ?3ìƒ?시험결과ì—? ì?˜í•˜ë©´ '페마ë?¼(Femara)'ë¡œ 잘 ì•Œë ¤ì§„ ì•„ë¡œë§ˆíƒ€ì œì°¨ë‹¨ì œì•½ë¬¼ì?¸ ë ˆíŠ¸ë¡œì¡¸ì?´ 내분비요법ì—? ë°˜ì?‘하는 ... 메디컬투데이 '넥사바'등 ìœ ë°©ì•” 약효 연구 ì?Ÿì•„ì ¸ - Dec 13, 2009 ...ë˜? ì?´ë²ˆ ìœ ë°©ì•” ì—°ë¡€ 심í?¬ì§€ì›€ì—?서는 ì—?스트로ê²?수용체 양성 ìœ ë°©ì•” 치료 실험약 'í”¼ë‹¤ë ˆìŠ¤íƒ€íŠ¸(Fidarestat)'와 '페마ë?¼(Femara)ì?˜ 병용치료 ìœ íš¨ì„±ì—? 관한 í…?사스대학 ... 헬스코리아뉴스 תרו לבעלי ×”×ž× ×™×•×ª: "×?× ×• מפצירי×? בכ×? להותיר ×?ת מועצת ×”×ž× ×”×œ×™×? ×”× ×•×›×—×™×ª בתפקידה" - Dec 13, 2009 ®Femara, תרופת המקור עליה מבוסס ×”-Letrozole, מצהירה בעלון לצרכן המצורף לתרופה ×›×™ "×?ין לקחת ×?ת ®Femara ב×?×? ×”×™× ×š בגיל פוריות... שכן ×”×™×? עלולה לגרו×? × ×–×§ לעובר. ... טלנירי Bisphosphonate könnten Brustkrebs vorbeugen - Dec 11, 2009 Hierauf deuten die Ergebnisse der Zometa-Femara Adjuvant Synergy Trial oder Z-FAST-Studie hin, an der 602 postmenopausale Frauen mit rezeptorpositiven ... Deutsches Ärzteblatt All for the breast - Nov 12, 2009 After starting drug treatments in June 2008, first with Femara and then in July 2008 with Herceptin (by intravenous drip), her tumors started to shrink. ... Del Mar Times A simple solution - Nov 12, 2009 The patient had tried unsuccessfully to get the hormone letrozole (marketed by Novartis Pharmaceuticals as Femara) at five different pharmacies and was ... Yellow Advertiser Drug for cancer is easier to find - Nov 10, 2009 The woman had tried unsuccessfully to get the hormone letrozole, which is marketed by Novartis Pharmaceuticals as Femara, at five different pharmacies. ... Essex Echo STUDY CONFIRMS AN OPTIMAL - Oct 29, 2009 Important results from one such clinical trial that were recently published in The New England Journal of Medicine (NEJM) show that a drug called Femara® ... North American Press Syndicate Novartis profit steady as vaccines, charges limit growth - Oct 22, 2009 Cancer drugs Zometa and Femara contributed $664 million to its top line. Vaccine and diagnostic sales dropped 18% after fewer H5N1 avian pandemic ... MarketWatch Solid quarter for Novartis as firm waits for swine flu windfall - Oct 22, 2009 Femara (letrozole), for women with hormone-sensitive breast cancer, climbed 14% to $329 million and Zometa (zoledronic acid) for cancer complications ... Pharma Times FaÅ‚szowaÅ‚ recepty i wyÅ‚udzaÅ‚ lekarstwa o wartoÅ›ci 1000 zÅ‚ - Oct 26, 2009 Szczególnym zainteresowaniem 20-latka cieszyÅ‚ siÄ™ onkologiczny lek "Femara", który oprócz leczenia, minimalizuje skutki uboczne dziaÅ‚ania sterydów i ... Gazeta.pl Aromasin nel trattamento del tumore al seno a insorgenza precoce - Nov 4, 2009 ...portato allo sviluppo degli inibitori dell'aromatasi di terza generazione, Anastrozolo ( Arimidex ), Letrozolo ( Femara ) ed Exemestane ( Aromasin ). ... XagenaSalute Nestlé schwächelt wegen anstehendem Verkauf - Nov 12, 2009 Dem Unternehmen drohe aufgrund von Patentabläufen bei Diovan, Femara, Zometa und Glivec ein Ertragseinbruch. Novartis könne die Kosten aber nicht ... Cash RPT/PREVISIONS/Novartis T3: bénefice net attendu entre 2046 et 2254 mio USD - Oct 21, 2009 ...des ventes des produits clés (Glivec, Zometa, Femara, Exelon ainsi que les médicaments dernièrement lancés Lucentis, Exjade, Exforge et Aclasta). ... Romandie.com WDH/AUSBLICK/Novartis Q3: Reingewinn von 2'161 Mio CHF erwartet - Oct 21, 2009 Analysten haben dazu folgende Schätzungen: FOKUS: Die meisten Analysten erwarten, dass sich das Umsatzwachstum der Schlüsselprodukte Glivec, Zometa, Femara ... Handelszeitung Online Novartis "outperform" - Oct 22, 2009 Novartis weise bis 2015 nach wie vor eines der besten Wachstumsprofile, sowohl bei Umsatz als auch Ergebnis je Aktie, auch wenn Femara in 2011 und Diovan in ... newratings.de Novartis "buy" - Oct 29, 2009 Novartis Pharmaceuticals werde durch die Generikaproduktion von so wichtigen Medikamenten wie Diovan, Zometa, Femara und Exelon belastet werden. ... newratings.de DJ HUGIN NEWS/Novartis verzeichnet in den ersten -6- - Oct 21, 2009 Femara (USD 925 Millionen, +16% in lokalen Währungen), ein Medikament zur oralen Behandlung von Frauen mit hormonsensitivem Brustkrebs, verzeichnete 2009 ... unternehmer.de Femara May Be Better Than Tamoxifen - Dec 28, 2005 By Daniel J. DeNoon. A large 27-nation clinical trial shows that postmenopausal women with estrogen-receptor-positive breast cancer are less likely to get ... FOXNews Novartis reports positive study results for Femara breast cancer... - Mar 23, 2006 BASEL (AFX) - Novartis AG announced positive study results for breast cancer treatment Femara in post-menopausal women with hormone-related early stage ... Forbes Femara Beats Tamoxifen for Breast Cancer - May 16, 2005 By Charlene Laino. Menopausal women with early breast cancer fare better if they are treated with Femara than if they are given the standard hormone therapy ... FOXNews Femara cuts cancer recurrence even if started late - Mar 10, 2008 By Julie Steenhuysen. CHICAGO (Reuters) - Taking the breast cancer pill Femara can significantly reduce the chances that a woman's cancer will return, ... Reuters Breast Cancer Drug Femara Beats Tamoxifen - Jan 27, 2005 Postmenopausal (search) women with early breast cancer have fewer recurrences after surgery when they take Femara (search) instead of tamoxifen (search), ... FOXNews Novartis Femara ok'd in Germany as inititial therapy after breast... - Mar 20, 2006 ZURICH (AFX) - Novartis AG said its Femara breat cancer drug has been approved in Germany for post-surgery use in postmenopausal women with ... Forbes Novartis, Mylan agree on Femara generic - Dec 2, 2008 ZURICH (Reuters) - Novartis AG (NOVN.VX) and Mylan Inc MYL.N have agreed a deal over Mylan's copy-cat version of Novartis's Femara breast cancer drug, ... Reuters Femara After Tamoxifen Can Reduce Breast Cancer Recurrence - Sep 8, 2005 By Jennifer Warner. New research backs up earlier reports that the breast cancer drug Femara can reduce the risk of breast cancer recurrence by nearly 50 ... FOXNews … submits new FDA, European applications for additional use of Femara... - Jul 11, 2005 Upon approval for this indication, Femara will become the only breast cancer ... Studies show that Femara reduces the risk of cancer returning by up to 30 ... Forbes Novartis' Femara gets FDA priority review for adjuvant early breast... - Aug 29, 2005 ...has granted its breast cancer drug Femara priority review for a new indication as adjuvant treatment for postmenopausal women with early breast cancer. ... Forbes Novartis's Zometa slows breast cancer bone loss combined with Femara ... - May 16, 2005 BASEL (AFX) - Novartis AG's Zometa slows bone loss in breast cancer patients also treated with the company's Femara drug, according to a study. ... Forbes Novartis says will defend rights on Femara - May 3, 2007 ZURICH, May 3 (Reuters) - Swiss drugmaker Novartis AG (NOVN.VX) will continue to defend its intellectual property rights on Femara after US approval of a ... Reuters Glaxo's Medicine Tykerb Slows Spread of Breast Cancer - Dec 11, 2008 All the women also received Novartis AG's Femara, which is already approved as an initial treatment. The results presented at the San Antonio Breast Cancer ... Bloomberg Novartis presents new data on breast cancer drug Femara - Dec 13, 2005 ZURICH (AFX) - Novartis AG said women with hormone-sensitive early breast cancer who switched to its Femara drug from placebo as part of a landmark trial ... Forbes Scottish approval for cancer drug - May 8, 2006 Women with breast cancer are set to benefit from a new drug, Femara, which has been ... Until now Femara, which is also known as Letrozole, has only been ... BBC News 'Grab a handful' training tapes scandal deepens - Apr 24, 2007 The tapes show reps how to raise doubts over the results of trials of Femara, and then switch back to discussing Arimidex's own positive trial data. ... Independent Femara® first aromatase inhibitor to indicate survival benefit versus... - Dec 11, 2008 Basel - New long-term data from a major international breast cancer study reports that postmenopausal woman with hormone receptor-positive early-stage ... webwire.com Hope for women as anti-cancer drug wins approval - May 23, 2006 Previous research has shown that Femara works better after surgery and cuts death rates by 39 per cent in women who took it after a long course of tamoxifen ... Times Online Femara Buy - Apr 20, 2007 ...psychopharmacology (effects of medication is a vital concern to medicine, Femara Buy also has strong economical and Femara Buy implications. ... Sokwanele Femara(R) Approved In Germany As Initial Therapy For Postmenopausal … - Mar 26, 2006 Novartis has announced that Femara(R) (letrozole) has received approval in Germany for use after surgery in postmenopausal women with hormone-sensitive ... Medical News Today - Medical News Today (press release) Breast Cancer Drug Not for Fertility - Nov 30, 2005 Femara isn't intended for use in fertility treatments. ... Femara is an aromatase inhibitor. It curbs production of estrogen, a female sex hormone which ... WebMD Atlanta Metro News | ajc.com - Dec 17, 2008 There were trends toward improved survival for women starting on Femara, but the differences were so small they could have occurred by chance alone. ... Atlanta Journal Constitution Wyeth Stops Breast Cancer Trial - Mar 16, 2006 The phase III trial involved the experimental drug temsirolimus plus the already-approved breast cancer drug Femara. The combination was being tested as a ... TheStreet.com - TheStreet.com (subscription) Purchase Femara Online - Aug 25, 2007 ...include clinical pharmacology (the medical field of medication on behavior and nervous system Purchase Femara Online toxicology and theoretical pharmacology ... Sokwanele ASCO data move cancer-drug stocks - MarketWatch - Jun 2, 2008 Novartis said that a Phase II study indicates its drug candidate RAD001 can increase the effectiveness of its breast-cancer drug Femara in women with newly ... MarketWatch Novartis Q1 net beats expectations on underlying growth, divestments ... - Apr 24, 2006 Net sales in Europe were down 7 pct in usd but rose 1 pct in local currencies with strong performances from Diovan, Glivec, Femara, Comtan/Stalevo and ... Forbes Femara Overnight - May 15, 2007 ...drugs. * Neuropharmacology - The Molecular and Behavior Femara Overnight Femara Overnight chemicals requires intimate knowledge Femara Overnight the drug. ... Sokwanele Femara Helped Significantly More Women With Early Breast Cancer Live ... - May 13, 2005 ...- Femara demonstrated significant advantage in disease free survival vs. tamoxifen, particularly in subgroups of postmenopausal women at increased risk of ... $4.95 - PR Newswire - ECNext Better chance at life - Nov 21, 2006 From December 1 the cancer drug Femara will become available on the nation's ... Cancer experts claim Femara reduces the risk of breast cancer returning in ... NEWS.com.au Cheap Femara COD - Aug 6, 2007 ...economical and political implications. To protect the consumer and prevent abuse, many governments regulate the manufacture, sale, and administration of ... Sokwanele Femara for metastatic disease? - Sep 22, 2008 Question from Valerie: What is the current research on the effectiveness of Femara on women who have been diagnosed with inoperable stage IV breast tumors? ... Breastcancer.org Canadian Regulators Warn Against Use of Femara as Fertility Drug - Nov 29, 2005 By Michael Smith,. OTTAWA, Nov. 29 - The aromatase inhibitor Femara (letrozole) -- approved as adjuvant breast cancer therapy in postmenopausal women -- can ... MedPage Today Order Femara - Nov 11, 2007 Cosmeceuticals * Order Femara Chinese Medicine * Crude drugs * Medicare Part D - the new prescription Order Femara plan in the UK. ... Sokwanele New 4-Year Data Confirm Letrozole Cuts Risk of Breast Cancer … - Oct 5, 2006 Importantly, the use of Femara resulted in substantial risk reduction in two ... In this group at 51-month median follow-up, Femara reduced the risk of ... DG News Buy Femara Online - Oct 20, 2007 ...* Carefully research the demand for their potential new product before spending an outlay of company Buy Femara Online * Obtain a patent on the body on the ... Sokwanele 'Lifeline' for sufferers of breast cancer as new drug approved - Mar 8, 2005 It means that Scottish clinicians can now prescribe Femara to all ... Femara, which slashes the chances of the disease returning after surgery, ... Scotsman Press Release: Video: Femara(R) First Aromatase Inhibitor to Indicate... - Dec 11, 2008 Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Femara Prevents Risk of Breast Cancer Relapse - Oct 2, 2006 LONDON OCT 02, 2006 (Reuters) - New 4-year clinical trial results confirm the effectiveness of Novartis"s drug Femara (letrozole) in cutting the risk of ... Cancerpage.com Novartis submits Femara for postmenopausal women with early breast … - Jul 12, 2005 Novartis has submitted marketing authorization applications in the United States and Europe for the use of Femara® (letrozole) in the adjuvant ... i-newswire.com Press Release: Femara(R) (letrozole) FIRST Aromatase Inhibitor to … - Dec 11, 2008 Femara(R) (letrozole) FIRST Aromatase Inhibitor to Indicate Overall Survival Benefit Versus tamoxifen When Taken for Five Years After Breast Cancer Surgery. Pay-Per-View - PR Newswire Europe - HighBeam Research Additional AstraZeneca staff disciplined - Apr 17, 2007 Letrozole is the generic name for Femara. Such direct comparison or counter-promotion of two drugs could be improper, since neither company has tested the ... $2.95 - Philadelphia Inquirer - NewsBank KEEP TAKING YOUR FEMARA - Dec 21, 2006 Dear Pharmacist: I've heard that exercising lowers a woman's risk for breast cancer. Why is that, and if I exercise, does that mean I can stop taking my ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Press Release: VIDEO: Femara(R) helps protect against return of... - Mar 10, 2008 VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy. from PR Newswire ... Pay-Per-View - PR Newswire - HighBeam Research Better Odds Against Breast Cancer - Jun 6, 2005 A study released at the prestigious American Society of Clinical Oncology (ASCO) meeting in May comparing the aromatase inhibitor Femara with tamoxifen ... BusinessWeek New Femara indications in US and UK - Feb 1, 2006 Femara is now the first and only aromatase inhibitor licensed for treatment across the entire breast cancer treatment spectrum--before surgery, ... Pay-Per-View - Med Ad News - Factiva, from Dow Jones Thailand calls off negotiations with European drug makers - Dec 19, 2007 A proposal to make or buy the medicines—Novartis' Femara, Sanofi's Taxotere and Roche's Tarceva—would be submitted to the health ministry on 21 December. ... Livemint Hogel appointed COO at Duquesne Light - Dec 3, 2008 Mylan Inc. said it has been granted a patent license to market letrozole tablets, the generic version of Femara, under the terms of a settlement with ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette Femara[R] approved in Germany as the only hormonal therapy given... - Mar 7, 2005 Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com EBCC: Zometa with Femara Sooner Better Than Later in Keeping Bone - Mar 23, 2006 By Michael Smith,. NICE, France, March 23 - Upfront treatment with Zometa (zoledronic acid) was significantly better than delayed Zometa at preserving bone ... MedPage Today … In Journal Of Clinical Oncology Support That Femara® Is More... - Feb 20, 2007 At a median follow-up of more than four years (51 months), Femara reduced the ... Femara significantly improved disease-free survival (a measure of disease ... Medical News Today - Medical News Today (press release) On the Move: Hilton, Telecom Italia, Renault - Dec 29, 2005 US regulators okayed Femara for a new indication: use by certain post menopausal women with early breast cancer immediately after surgery. ... BusinessWeek Drugmaker warns not to use drug for fertility - Dec 7, 2005 Novartis AG has sent a letter warning doctors not to use Femara, ... Femara, one of seven drugs on the market that Novartis is targeting to have sales of ... Pay-Per-View - Chicago Tribune - ProQuest Archiver SHOT STOPS ONE PNEUMONIA - Sep 9, 2007 We visited a reproductive endocrinologist, who put me on Femara, a drug for breast ... Femara hasn't been sanctioned by the Food and Drug Administration. ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver … submits applications in US and Europe for Femara(R) as adjuvant … - Nov 7, 2005 EAST HANOVER, NJ, July 11 /PRNewswire/ -- Novartis has submitted marketing authorization applications in the United States and Europe for the use of ... FinanzNachrichten.de Femara approved for post-surgery treatment - Jan 19, 2006 The drugmaker Novartis announces US regulatory approval of Femara (letrozole) as a treatment for use after surgery in postmenopausal women with ... DentalPlans.com Breast Cancer Drug Good Later Than Thought - Mar 11, 2008 New research shows that women can follow up with the drug, Femara, ... It had been thought for a long time that Femara is only useful when begun almost ... CBS News Femara Link To Birth Defects Called Incorrect - Apr 21, 2006 By Michael Smith, MedPage Today Staff Writer. MONTREAL, April 21 — Concern about congenital malformations arising from the off-label use of Femara ... MedPage Today US FDA gives priority review to Novartis' Femara in new indication.( … - Sep 5, 2005 The US Food and Drug Administration has granted priority review to Swiss drug major Novartis' Femara (letrozole), a once-daily aromatase inhibitor, ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Breast Cancer; Study: Femara provides survival advantage vs. tamoxifen... - Feb 22, 2005 2005 FEB 22 - (NewsRx.com & NewsRx.net) -- Adjuvant use of Femara (letrozole tablets) in postmenopausal women with hormone receptor-positive early breast ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones … submits applications in US and Europe for Femara(R) as adjuvant … - Jul 11, 2005 Novartis submits applications in US and Europe for Femara(R) as adjuvant treatment for postmenopausal women with early breast cancer. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Oct. 19, 2008; lumpectomy, chemotherapy, MammoSite radiation, Femara... - Oct 19, 2008 After her fraternal twin sister died of breast cancer in 1994, Mrs. Grooms got yearly mammograms. "I saw my sister battle this disease for two years and how ... Augusta Chronicle International Approvals: Femara, Xyrem, Duodopa - Dec 12, 2005 Dec. 12, 2005 — The UK Medicines and Healthcare Products Regulatory Agency has approved letrozole tablets for the adjuvant treatment of postmenopausal women ... Medscape Press Release: Femara(R) Granted FDA Priority Review for New … - Aug 29, 2005 Femara(R) Granted FDA Priority Review for New Indication as Adjuvant Treatment for Postmenopausal Women with Early Breast Cancer. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Femara[R] (letrozole tablets).(Product/Service Evaluation) - Sep 1, 2005 Introducing Femara. After breast cancer, after tamoxifen, there's something more you can do to increase your chances of staying cancer free. ... Free with registration - O, The Oprah Magazine - AccessMyLibrary.com Breast Cancer: Hormone Therapy Overview - Sep 1, 2006 Specifically, Femara and Arimidex are used as part of the initial or follow-up treatment of hormone-sensitive breast cancer (even those that have spread to ... WebMD Cognitive decline, supplements, breast cancer - Jan 29, 2006 The study was funded by Novartis, which makes Femara; company employees were members of a committee that reviewed the article, and seven of 14 primary ... Seattle Times Press Release: Femara Helps More Women Live Breast Cancer-Free. - … - Dec 29, 2005 Femara Helps More Women Live Breast Cancer-Free. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Breast cancer drug funds reviewed - Jun 12, 2005 The drugs, known as aromatase inhibitors and marketed as Femara and Arimidex, ... Pharmac is considering subsidising Femara and Arimidex only for women with ... TVNZ … : New Clinical Data Show Dramatic Benefits of Femara(R) for Women... - Dec 13, 2005 New Clinical Data Show Dramatic Benefits of Femara(R) for Women with Breast Cancer Even After Prolonged Period of No Anti-Cancer Treatment. from PR Newswire ... Pay-Per-View - PR Newswire - HighBeam Research Make Femara available to women - Jan 11, 2006 I just heard that a new drug is proving to be effective against the return of breast cancer and the onset of ovarian and colon cancer in women. ... $2.95 - Berkshire Eagle, The - NewsBank … Release: First Results of Major Study Show that Femara(R) Provides... - Jan 26, 2005 First Results of Major Study Show that Femara(R) Provides a Disease Free Survival Advantage vs. Tamoxifen in Adjuvant Treatment of Early Breast Cancer; ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Femara Helps More Women Live Breast Cancer-Free. - … - Dec 29, 2005 Femara Helps More Women Live Breast Cancer-Free. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research SABCS: Femara Beneficial Even Years After Tamoxifen Ends - Dec 9, 2005 By Michael Smith,. SAN ANTONIO, Dec. 9 - Taking the aromatase inhibitor Femara (letrozole) -- even years after stopping treatment with tamoxifen -- offers a ... MedPage Today Breast Cancer; Study: Femara provides survival advantage vs. tamoxifen... - Feb 26, 2005 2005 FEB 26 - (NewsRx.com & NewsRx.net) -- Adjuvant use of Femara (letrozole tablets) in postmenopausal women with hormone receptor-positive early breast ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Aromatase Inhibitors Better Than Tamoxifen After Surgery for Early... - Jan 26, 2006 The longer you take Femara (up to five years) after tamoxifen, the lower your risk of ... Femara is made by Novartis. Call Ribbon of Pink at 800-282-7630. ... Breastcancer.org Femara Appears Safe as Fertility Agent These drugs increase fertility... - May 11, 2006 By Carmen Ivanov, Associate Editor. Femara (letrozole), an inexpensive, easy-to-use fertility agent, is just as safe as clomiphene citrate, a drug that has ... Softpedia More women to receive new drugs - Aug 1, 2005 Aromatase inhibitor drugs such as letrozole and anastrozole, marketed as Femara and Arimidex are already funded for women with advanced breast cancer. ... TVNZ DRUG AID IN NHS FIGHT ON CANCER - Nov 22, 2006 The Government's drugs watchdog has approved the use of Arimidex, Femara and Aromasin alongside "gold standard" drug Tamoxifen. ... Mirror.co.uk Custom Treatment For Breast Cancer Victims - Dec 18, 2006 That tiny pill is called Femara. It's a form of hormone therapy that shuts off her body's estrogen production, keeping the cancer at bay and the 58-year-old ... CBS News FEMARA GETS APPROVAL FOR TREATMENT OF POSTMENOPAUSAL … - Jan 3, 2006 Novartis has announced the US regulatory approval of Femara (letrozole) in a new indication as a treatment for use after surgery in postmenopausal women ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones Study: Drug slows breast cancer recurrence - Mar 16, 2008 Hyman Muss of the University of Vermont did a further analysis and found that letrozole, which is sold under the brand name Femara, was effective in cutting ... $2.95 - Kansas City Star - NewsBank … Release: Newly Published Study Reveals Femara(R) Improves Chances ... - Apr 30, 2007 Newly Published Study Reveals Femara(R) Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research New breast cancer drug 21 percent as effective as tamoxifen in … - Dec 30, 2005 The study looked at the effects of tamoxifen and Femara when used as the first drug ... It was found that Femara was successful in bringing down the risk of ... earthtimes.org Article: Novartis' Femara.(Pipeline) - Medical Marketing & Media | … - Apr 1, 2005 Novartis' Femara.(Pipeline) ... find Medical Marketing & Media articles. Novartis' Femara has received marketing authorization in Germany for the treatment ... Pay-Per-View - Medical Marketing & Media - HighBeam Research NOVARTIS FEMARA ACCESS PROGRAMME MAKES EARLY BREAST … - Jun 8, 2006 Novartis New Zealand Limited has launched an access programme to make Femara (letrozole) more affordable for women with breast cancer. ... Pay-Per-View - Mediacom - Factiva, from Dow Jones Novartis warns doctors on off-label Femara use - Nov 30, 2005 ZURICH (Reuters) - Novartis has warned doctors not to use its hormone-based breast cancer drug Femara to help women become pregnant after reports of adverse ... RedOrbit Press Release: Femara Endorsed Post-Surgery for Women With Early … - May 8, 2006 Femara Endorsed Post-Surgery for Women With Early Breast Cancer in Scotland...But Women in the Rest of the UK Must Wait a Further 6 Months. from PR Newswire ... Pay-Per-View - PR Newswire Europe - HighBeam Research Postmenopausal Women With Breast Cancer Who Switch to Letrozole … - Jun 15, 2006 Overall, women in the MA-17 study who switched from placebo to Femara ... "These data further support that women can benefit from Femara even years after ... DG News Press Release: Femara(R) Receives US Approval as Initial Therapy for ... - Dec 29, 2005 Femara(R) Receives US Approval as Initial Therapy for Treatment of Postmenopausal Women With Early Breast Cancer After Surgery. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Letrozole (Femara, Novartis) improves event free survival as adjuvan ... - Apr 3, 2006 Obviously a new post menopausal breast cancer patient would start on Femara or another aromatase inhibiting drug immediately post operatively instead of ... Gerson Lehrman Group HORMONE-BASED BREAST CANCER TREATMENT SUBSIDISED. - Jan 5, 2005 The drug letrozole (marketed as Femara) is one of a new class of hormonal ... Femara has been reported to be more effective and have fewer side effects for ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Femara to Drive Growth of Novartis Pharma - Mar 6, 2006 Novartis Pharma regards the post-menopausal breast cancer treatment Femara (letrozole) as a product central to its future growth. Femara was approved in ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Treat heartburn, catch more ZZZZs - Sep 4, 2005 The drug Femara was granted priority review from federal regulators for use in helping to prevent breast cancer from recurring in older women who have had a ... $2.95 - Chicago Sun-Times - NewsBank FDA approves Novartis' Femara in post operative breast cancer... - Jan 9, 2006 Swiss drug major Novartis says that the US Food and Drug Administration has approved Femara (letrozole) in a new indication as a treatment for use after ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Strong patient data for Novartis' Femara.(Brief article) - Apr 3, 2006 Swiss drug major Novartis says that women with hormone-sensitive early breast cancer switched to its aromatase inhibitor Femara (letrozole) from placebo ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Q4 2004 Novartis Corporation Earnings Presentation & Conference … - Jan 20, 2005 But we are pressing forward looking at Femara in combination with other agents. ... In fact, one of these setting combinations is the combination of Femara ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com … Release: Newly Published Study Reveals Femara(R) Improves Chances ... - Apr 30, 2007 Newly Published Study Reveals Femara(R) Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research DR. PAUL DONOHUE GOOD HEALTH - Jul 3, 2005 A new class of adjuvant drugs, which includes Femara, Arimidex and Aromasin, reduces the production of even the small amounts of estrogen that ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Press Release: New Data Show Femara Helps Significantly More Women … - May 15, 2005 New Data Show Femara Helps Significantly More Women With Early Breast Cancer Survive Cancer-Free. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Femara approved as initial Tx.(drug approval)(Brief article) - Apr 1, 2006 Femara (letrozole) is indicated as a treatment for use after surgery in postmenopausal women with hormone-sensitive early breast cancer (adjuvant setting). ... Free with registration - Internal Medicine News - AccessMyLibrary.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |